Zusammenfassung
Der Schwangerschaftsabbruch oder induzierte Abort wurde noch vor 25 Jahren in der allgemeinen Terminologie als krimineller Abort bezeichnet. Seitdem sind die Abortgesetze in vielen Ländern liberalisiert worden. Daraufhin sank die mütterliche Mortalität, und die Zahl der legalen Aborte stieg an. Im Gegensatz zu Japan, China und der damaligen Sowjetunion wurde der induzierte Abort in den westlichen Ländern nur als eine Notlösung und nicht als eine Methode der Familienplanung angesehen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abortion Surveillance: preliminary data United States (1991) MMWR 43: 42–44
Alan Guttmacher Institute (1996) Facts in brief: induced abortion. The Alan Guttmacher Institute, New York
AMA Report (1997) Concerning H.R. 1122, the »Partial Abortion Act of 1997«
Ashok PW, Penney GC, Flett GM et al. (1998) An effective regimen for early abortion: a report of 2000 consecutive cases. Hum Reprod 13: 2962–2965
Atrash HK, on HW, Smith JC (1990) Legal abortion in the US, trends and mortality. Contemp Ob Gyn 35: 58–69
Baird DT, Sukcharoen N, Thong KJ (1995) Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion. Hum Reprod 10: 1521–1527
Beaulieu EE, Segal SJ (eds) (1985)The antiprogesterone steroid RU 486 and human fertility control. Plenum, New York
Beller FK (1972) Pathophysiologische Aspekte des septischen Schocks während der Schwangerschaft. Z Rechtsmedizin 70: 55–67
Beller FK (1996) Wie klein ist zu klein, wie groß ist zu groß?. Frauenarzt 37: 929–933
Beller FK, DeProsse CHA (1992) The confusion of trimester and viability and the consequences for the abortion law. J Reprod Med 37: 537–540
Beller FK, Zlatnik P (1994) Medical aspects of the beginning of human life. In: Beller FK, Weir RF (eds) The beginning of human life. Kluwer, Dordrecht, PP 3–19
Binkin N (1986) Trends in induced legal abortion morbidity and mortality. Clin Obst Gynecol 13: 83–93
Bottoms SF, Paul RH, lams JD et al. (1997) Obstetrical determinants of neonatal survival: influence of willingness to perform cesarean section delivery on survival of extremly low-birth-weight. Am J Obstet Gynecol 176: 960–966
Calder L, Pempleton A (1995) Induction of abortion with mifepriston (RU 486) and oral or vaginal misoprostol. N Engl J Med 332: 983–987
Carbonell JLI, Varela L, Velazco A et al. (1999) Early abortion with 800 ug of misopristol by the vaginal route. Contraception 59: 219–225
Cates W Jr, Grimes DA (1981) Morbidity and mortality of abortion in the United States. In: Hofgeson JE (ed) Abortion and sterilization. Medical and social aspects. Academic Press, New York, pp 155–180
CDC (1980) Abortion surveillance 1978. Centers for Disease Control, Atlanta/GA
Chervenak FA, McCullogh LB, Campbell S (1995) Is third trimester abortion justified?. Br J Obstet Gynaecol 102: 434–435
Creinin MD, Darney PD (1993) Methotrexate and misoprostol for early abortion. Contraception 48: 339–342
Creinin MD, Moyer R, Guido R (1997) Misoprostol for medical evaluation of early pregnancy. Obstet Gynecol 89: 768–72
Creinin MD, Pymar HC (2001) Mifepristone 100 mg in abortion regimens. Obstet Gynecol 98: 434–439
El-Rafaey H, Rasekar D, Abdalla M (1995) Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 332: 983–987
El-Rafaey H, Rajasekar D, Abdalla M, Calder L, Templeton A (1995) Induction of abortion with mifepristone (RU 486)
Fathalla MF (1997) Gesellschaft und menschliche Reproduktion. Festrede FIGO-Kongress Kopenhagen, Okt. 1997
Glasier AKJ, Thong M, Dewar M, Makie DT, Baird DT (1992) Mifepristone (RU 468) compared with high dose estrogen and progestogen for emergency postcoital contraception. N England J Med 327: 1041–1044
Graeves D, Evans M, Morgan D, Pickering N, Upton M (1992) Bioethics in the United Kingdom and Ireland, 1989–91. In: Lustig A (ed) Bioethics Yearbook, vol 2B. Kluwer, Dordrecht, pp 127–152
Grimes DA, Cook RJ (1992) Mifepristone (RU 486), an abortificiant to prevent abortion. N Engl J Med 327: 1088–1089
Grimes DA, Schulz KF, Cates W Jr (1984) Prophylactic antibiotics for curettage. Am J Obstet Gynecol 150: 689–1000
Grimes DA, Stubblefield PG (1999) A clinician guide to medical and surgical abortion. Churchill Livingstone, New York, pp 192–216
Grou F, Rodrigues I (1994) The morning-after pill — how long after?. Am J Obstet Gynecol 171: 1529–1534
Hankins I, Gary DV (1994) Operative obstetrics. Appleton & Lange, Stamfort/CT, p 614
Hausknecht RU (1995) Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 333: 537–540
Henshaw SK, Morrow E (1990) Induced abortion, a world review. Fam Plann Perspect 22: 76–120
Hepp H (1996) Pränatalmedizin und reformierter § 218a StGB — oder: die versteckte Indikation. Gynäkologe 29: 407–411
Jain JK, Meckstroh M, Park M (2000) A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination. Amer J Obstet Gynecol 60: 353–356
Jurema M, Wallach EE, Blumenthal PD (2001) Mifepristone for medical abortion: A review. Biweekly Rev Clin Ob Gyn 21: 1–5
Koonin LM, Smith JC, Ramick M, Lawson HW (1992) Abortion surveillance United States 1989. MMWR 41/5: 1–33
Koonin LM, Strauss LT, Chrisman CE et al. (1999) Abortion surveillance — United States 1966. MMWR Morb Mortal WKLY REP 48: 1–42
Lawson HW, Atrash HK, Saftlas AF, Finch EL (1981) Abortion surveillance United States 1984–1985. MMWR Surv Sum 38 (SS-2): 11
Lawson HW, Frye A, Atrash H et al. (1994) Abortion mortality United States 1972–1987. Am J Obstet Gynecol 171: 1365–2000
Lindblom B (1992) Ectopic pregnancy — laparoscopic and medical treatment. Curr Opin Obstet Gynecol 4: 400–405
Lippes J, Malik T, Tatum HJ (1976) The post coital copper T. Adv Plann Parenthood 11: 24–100
MacIsaac L, Creinin MD (2000) Early surgical abortion an alternative and backup for medical abortion. Amer J Obstet Gynecol 183: 76–83
Mahler H (1987) The safe motherhood initiative: a call to action. Lancet 1: 668–670
McCullogh LB, Chervenak FA (1994) Ethics in obstetrics and gynecology. Oxford University Press
McKinley C, Thong KJ, Baird DT (1993) The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 8: 1502–1505
Melby M, Wohlfahrt J, Olsen J, Frisch M, Westergaard T, Hellweg Larsen KH, Andersen PK (1997) Induced abortion and the risk of breast cancer. N England J Med 336: 81–85
Müller TJ, Backe A, Rempen A (1996) Vorzeitige Schwangerschaftsbeendigung im II. und III.Trimenon. Geburtsh Frauenheilk 56: 234–238
Mund M (2001) Der medikamentöse Schwangerschaftsabbruch mit Mifepriston. Frauenarzt 42: 952
Ngai SW, Yeung KCA, Lao T (1996) Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomised study. Br J Obstet Gynaecol 103: 1120–1123
Paul M, Schaff E, Nichols MT (2000) The roles of clinical assessment, human chorionic gonadotropin assay and ultrasonography in medical practice. Am J Obstet Gynecol 183: 34–43
Paul M, Lackie E, Mitchell C et al. (2002) Is pathology examination useful after early surgical abortion. Obstet Gynecol 99: 567–571
Peyron R, Aubry E, Targosz V, Silvestre L, Renault M, Elkik F et al. (1993) Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N England J Med 328: 1509–1513
Pirruccello EP, Newhall MD, Winikoff R (2000) Abortion with mifepristone and misoprostol: Regimens acceptability and future directions. Maer J Obstet Gynecol 183: 44–53
Policar MJ, Pollack AE (eds) (1995) Clinical training curriculum in abortion practice. National Abortion Federation, Washington DC
Querido L, Haspels AA (1990) Late second trimester abortion with 16, 16 dimethyl transdelta 2-PGE1 methylester (Gemeprost). Contraception 42: 43–49
Rath W, Osmers K, Stuhlsatz HW, Adelmann-Grill BC (1996) Geburtseinleitung mit Prostaglandinen. Nutzen und Risiken. In Rath W (Hrsg) Fortschritte in der medikamentösen Geburtseinleitung, 2. Aufl. HUF, Mühlheim, S 39
Ross GT, Goldstein M, Hertz R et al. (1965) Sequential use of methotrexate and actinomycin D in the treatment of metastatic chorion carcinoma and related throphoblastic disease in women. Am J Obstet Gynecol 150: 189
Rymar HC, Creinin MD (2000) Alternatives to mifepristone regimens for medical abortion. Amer J Obstet Gynecol 183: 54–64
Schaff EA, Penmeetsa U, Eisinger STH, Franks P (1997) Methotrexate — a single agent for abortion. J Reprod Med 42: 56–60
Schaff EA, Stadalius LS, Eisinger SH et al. (1997) Vaginal misoprostol at home after mifepristone. J Fam Pract 44: 353–360
Schneider D, Halparin R, Langer R, Caspi E, Bukowski I (1996) Abortion at 18–22 weeks by laminaria dilatation and evacuation. Obstet Gynecol 88: 412–414
Schüssler B (1997) Prostaglandinanwendung in Gynäkologie und Geburtshilfe. Standard-Therapiekonzepte und neue Alternativen. Frauenheilkd Aktuell 1: 4–8
Spitz IM, Bardin CW, Benton L et al. (1998) Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338: 1241–1247
Stoval TG, Ling FW (1993) Single dose methotrexate: an expanded dilatation trail. Am J Obstet Gynecol 48: 339–348
Stubblefield PG (1986) Pregnancy termination. In: Gabbe SG, Niebyl JR, Simpson JL (eds) Obstetrics. Normal and problem pregnancy. Churchill Livingstone, New York, p 1051
Task Force (1999) Postovulatory Methods for Fertility Regulation: Randomised controll trial of levonogestrel vs the Yupze regimen of combined oral contraception for emergency contraception. Lancet 352: 428–433
Tietze C, Lewit S (1972) Joint program for the study of abortion early medical complication of legal abortion. Stud Fam Plann 3: 97–101
Thong KJ, Baird DT (1992) An open study comparing two regimens of Gemeprost for the termination of pregnancy in the second trimester. Acta Obstet Gynecol Scand 71: 191–196
Webb AMC (1991) Alternative treatment in oral postcoital contraception, interim results. Adv Contracept 7: 271–275
Westfall JM, Sophocles A, Burggraf H et al. (1998) Manual vacuum aspiration for trimester abortion. Arch Fam Med 7: 559–562
WHO (1991) Pregnancy termination with mifepristone and gemeprost. A multicenter comparison between repeated doses and a single dose of mifepristone. Fertil Steril 56: 32–40
Wiebe ER (1997) Abortion induced with methotrexate and misoprostol. A comparison of various protocolls. Contraception 55: 159–163
Wiebe ER (1999) Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion. Amer J Obst Gynecol 181: 149–152
Wiebe ER, Dunns G, Gilbert E et al. (2002) Comparison of abortions induced by methotrexate or Mifepristone followed by Misoprostol. Obstet Gynecol 99: 813–819
Winkler M, Rath W (1997) Aktuelles Vorgehen bei der vorzeitigen Schwangerschaftsbeeendigung mit Prostaglandinen im II. und III.Trimenon. Z Geburtsh Neonatol 201: 39–43
Winkler CL, Gray SE, Hauth JC, Owen J, Tucker JM (1991) Mid second trimester labor induction, concentrated oxytocin compared with Prostaglandin E2 Supp. Obstet Gynecol 77: 297–300
Wood SL, Brain PH (2002) Medical management of missed abortion. A randomized clinical trial. Obstet Gynecol 99: 563–566
Yupze A, Smith RP, Rademaker AW (1982) A multicenter clinical trial investigation employing ethinylestradiol combined with dl-norgestrel as a postcoital contraceptive agent. Fertil Steril 37: 508–513
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Beller, F.K. (2004). Schwangerschaftsabbruch. In: Schneider, H., Husslein, P., Schneider, KT.M. (eds) Die Geburtshilfe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18574-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-18574-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30522-4
Online ISBN: 978-3-642-18574-8
eBook Packages: Springer Book Archive